KATIE WALLER: Open Payments
NPI 1043074396 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $540 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $198 |
| ABBVIE INC. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $11 |
Products named: Auvelity, VRAYLAR, ABILIFY MAINTENA, CAPLYTA, INGREZZA, LifeVest.
Industry payments across AR — which companies pay providers there.
